ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 166 filers reported holding ANI PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 6.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $834,000 | -58.6% | 13,525 | -51.1% | 0.08% | -47.4% |
| Q3 2019 | $2,014,000 | -82.5% | 27,632 | -80.2% | 0.15% | -81.5% |
| Q2 2019 | $11,490,000 | +20.3% | 139,783 | +3.2% | 0.82% | +18.3% |
| Q1 2019 | $9,551,000 | -99.8% | 135,399 | +10.4% | 0.70% | +55.8% |
| Q4 2018 | $5,521,208,000 | +14.9% | 122,639 | +44.3% | 0.45% | +43.9% |
| Q3 2018 | $4,804,317,000 | -1.7% | 84,972 | +16.1% | 0.31% | -12.2% |
| Q2 2018 | $4,887,489,000 | +128.1% | 73,166 | +98.8% | 0.35% | +119.3% |
| Q1 2018 | $2,142,787,000 | +150.6% | 36,805 | +177.5% | 0.16% | +140.3% |
| Q4 2017 | $854,929,000 | +51.8% | 13,265 | +23.6% | 0.07% | +39.6% |
| Q3 2017 | $563,375,000 | +12.2% | 10,733 | 0.0% | 0.05% | +4.3% |
| Q2 2017 | $502,304,000 | -16.0% | 10,733 | -11.2% | 0.05% | -22.0% |
| Q1 2017 | $598,229,000 | – | 12,083 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |